Skip to main content

Table 4 Diagnostic accuracy of Microlife WatchBP AFIB in DM patients of different age groups

From: Targeted screening of atrial fibrillation using automated blood pressure measurement device with atrial fibrillation detection function, in patients with type 2 diabetes mellitus in primary care setting

 

All

Age < 65

Age 65–74

Age ≥ 75

Sensitivity (%) (95% CI)

80.0 (61.8–92.3)

33.3 (23.0–83.9)

83.3 (56.9–97.0)

90.0 (62.8–99.4)

Specificity (%) (95% CI)

97.9 (97.3–98.5)

98.6 (97.7–99.2)

97.7 (96.5–98.6)

96.9 (94.9–98.3)

PPV (%) (95% CI)

32.8 (21.9–45.1)

7.7 (5.0–29.7)

37.0 (20.6–55.8)

42.9 (23.4–63.9)

NPV (%) (95% CI)

99.7 (99.5–99.9)

99.8 (99.3–100)

99.7 (99.2–100)

99.7 (98.8–100)

Positive LR (95% CI)

38.8 (27.1–55.7)

23.7 (4.4–29.3)

36.6(21.4–62.4)

29.2 (16.1–52.8)

Negative LR (95% CI)

0.2 (0.1–0.5)

0.7 (0.3–1.5)

0.2 (0.05–0.6)

0.1 (0.02–0.66)